| Temozolomide versus standard 6-week radiotherapy versus hypofractionated radiotherapy in patients older than 60 years with glioblastoma: the Nordic randomised, phase 3 trial A Malmström, BH Grønberg, C Marosi, R Stupp, D Frappaz, H Schultz, ... The lancet oncology 13 (9), 916-926, 2012 | 1360 | 2012 |
| Phase III study by the Norwegian lung cancer study group: pemetrexed plus carboplatin compared with gemcitabine plus carboplatin as first-line chemotherapy in advanced Non … BH Grønberg, RM Bremnes, Ø Fløtten, T Amundsen, PF Brunsvig, ... Journal of clinical oncology 27 (19), 3217-3224, 2009 | 403 | 2009 |
| Changes in skeletal muscle mass during palliative chemotherapy in patients with advanced lung cancer GB Stene, JL Helbostad, T Amundsen, S Sørhaug, H Hjelde, S Kaasa, ... Acta oncologica 54 (3), 340-348, 2015 | 233 | 2015 |
| Nordic Clinical Brain Tumour Study Group (NCBTSG). Temozolomide versus standard 6-week radiotherapy versus hypofractionated radiotherapy in patients older than 60 years with … A Malmström, BH Grønberg, C Marosi, R Stupp, D Frappaz, H Schultz, ... Lancet Oncol 13 (9), 916-926, 2012 | 210 | 2012 |
| Muscle mass and association to quality of life in non‐small cell lung cancer patients A Bye, B Sjøblom, T Wentzel‐Larsen, BH Grønberg, VE Baracos, ... Journal of cachexia, sarcopenia and muscle 8 (5), 759-767, 2017 | 149 | 2017 |
| Influence of comorbidity on survival, toxicity and health-related quality of life in patients with advanced non-small-cell lung cancer receiving platinum-doublet chemotherapy BH Grønberg, S Sundstrøm, S Kaasa, RM Bremnes, Ø Fløtten, ... European journal of cancer 46 (12), 2225-2234, 2010 | 141 | 2010 |
| Geriatric assessment is superior to oncologists’ clinical judgement in identifying frailty L Kirkhus, J Šaltytė Benth, S Rostoft, BH Grønberg, MJ Hjermstad, ... British journal of cancer 117 (4), 470-477, 2017 | 138 | 2017 |
| Skeletal muscle radiodensity is prognostic for survival in patients with advanced non-small cell lung cancer B Sjøblom, BH Grønberg, T Wentzel-Larsen, VE Baracos, MJ Hjermstad, ... Clinical Nutrition 35 (6), 1386-1393, 2016 | 137 | 2016 |
| Cancer cachexia associates with a systemic autophagy-inducing activity mimicked by cancer cell-derived IL-6 trans-signaling K Pettersen, S Andersen, S Degen, V Tadini, J Grosjean, S Hatakeyama, ... Scientific reports 7 (1), 2046, 2017 | 119 | 2017 |
| The length of consent documents in oncological trials is doubled in twenty years O Berger, BH Grønberg, K Sand, S Kaasa, JH Loge Annals of Oncology 20 (2), 379-385, 2009 | 101 | 2009 |
| Low muscle mass is associated with chemotherapy-induced haematological toxicity in advanced non-small cell lung cancer B Sjøblom, BH Grønberg, JŠ Benth, VE Baracos, Ø Fløtten, MJ Hjermstad, ... Lung Cancer 90 (1), 85-91, 2015 | 94 | 2015 |
| High-dose versus standard-dose twice-daily thoracic radiotherapy for patients with limited stage small-cell lung cancer: an open-label, randomised, phase 2 trial BH Grønberg, KT Killingberg, Ø Fløtten, OT Brustugun, K Hornslien, ... The Lancet Oncology 22 (3), 321-331, 2021 | 87 | 2021 |
| Prolonged survival in patients with lung cancer with diabetes mellitus P Hatlen, BH Grønberg, A Langhammer, SM Carlsen, T Amundsen Journal of Thoracic Oncology 6 (11), 1810-1817, 2011 | 84 | 2011 |
| Randomized phase II trial comparing twice daily hyperfractionated with once daily hypofractionated thoracic radiotherapy in limited disease small cell lung cancer BH Grønberg, TO Halvorsen, Ø Fløtten, OT Brustugun, PF Brunsvig, ... Acta Oncologica 55 (5), 591-597, 2016 | 76 | 2016 |
| Does chemotherapy improve health-related quality of life in advanced pancreatic cancer? A systematic review A Kristensen, OM Vagnildhaug, BH Grønberg, S Kaasa, B Laird, ... Critical reviews in oncology/hematology 99, 286-298, 2016 | 68 | 2016 |
| Cancer patients’ knowledge about their disease and treatment before, during and after treatment: a prospective, longitudinal study O Berger, BH Grønberg, JH Loge, S Kaasa, K Sand BMC cancer 18, 1-11, 2018 | 63 | 2018 |
| Glioblastoma (GBM) in elderly patients: A randomized phase III trial comparing survival in patients treated with 6-week radiotherapy (RT) versus hypofractionated RT over 2 … A Malmstrom, BH Grønberg, R Stupp, C Marosi, D Frappaz, HP Schultz, ... Journal of Clinical Oncology 28 (18_suppl), LBA2002-LBA2002, 2010 | 59 | 2010 |
| Drug dose per kilogram lean body mass predicts hematologic toxicity from carboplatin-doublet chemotherapy in advanced non–small-cell lung cancer B Sjøblom, JŠ Benth, BH Grønberg, VE Baracos, MB Sawyer, Ø Fløtten, ... Clinical lung cancer 18 (2), e129-e136, 2017 | 56 | 2017 |
| Characterization of patients receiving palliative chemo-and radiotherapy during end of life at a regional cancer center in Norway M Anshushaug, MA Gynnild, S Kaasa, A Kvikstad, BH Grønberg Acta Oncologica 54 (3), 395-402, 2015 | 55 | 2015 |
| Modifiable factors affecting older patients' quality of life and physical function during cancer treatment L Kirkhus, M Harneshaug, JŠ Benth, BH Grønberg, S Rostoft, S Bergh, ... Journal of Geriatric Oncology 10 (6), 904-912, 2019 | 54 | 2019 |
